Halozyme Therapeutics reported $153.2M in Trade Debtors for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Acadia Pharmaceuticals ACAD:US $ 51.82M 5.57M
Alnylam Pharmaceuticals ALNY:US $ 646.59M 35.96M
Amarin AMRN:US $ 182.26M 30.98M
Amgen AMGN:US $ 4479M 56M
Aptinyx Inc APTX:US $ 0 0
Baxter International BAX:US $ 2021M 106M
Cara Therapeutics CARA:US $ 1M 2.75M
Cytokinetics CYTK:US $ 2.7M 1.81M
Eli Lilly And LLY:US $ 6902.8M 244.2M
Esperion Therapeutics ESPR:US 21.85M 401K
Halozyme Therapeutics HALO:US $ 153.2M 64.81M
Immunogen IMGN:US $ 20.36M 0.68M
Intercept Pharmaceuticals ICPT:US $ 45.25M 2.66M
Intra Cellular Therapies ITCI:US $ 15.19M 1.53M
Intrexon XON:US $ 26.67M 5.31M
JAZZ PHA JAZZ:US $ 506.66M 92.68M
Mannkind MNKD:US $ 6.3M 2.73M
Nektar Therapeutics NKTR:US $ 28.87M 0.28M
Peregrine Pharmaceuticals PPHM:US $ 24.31M 0.64M
Rigel Pharmaceuticals RIGL:US $ 17.37M 124.82M
United Therapeutics UTHR:US $ 173.4M 32.3M
Vanda Pharmaceuticals VNDA:US $ 37.09M 5.62M